eutral immersion bath on Myalgia in patients with post COVID-19
Phase 2
Completed
- Conditions
- Health Condition 1: M791- Myalgia
- Registration Number
- CTRI/2022/12/047993
- Lead Sponsor
- Dr SHRAVYA C
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1.Subjects who are willing to participate in the study.
2.Post COVID-19 subjects with RTP-CR negative after COVID-19 infection.
Exclusion Criteria
1.Subjects with active COVID-19 or RTP-CR positive patients.
2.Subjects with COVID-19 and other comorbidities.
3.Post COVID-19 subjects who are under statins.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method niversal Pain Assessment Tool (UPAT) <br/ ><br>Timepoint: After 10 days- <br/ ><br>0-10 scale of Universal Pain Assessment Tool (UPAT) reading should be towards 0. <br/ ><br>
- Secondary Outcome Measures
Name Time Method Brief Pain Inventory (BPI):Timepoint: After 10 days- <br/ ><br>0-10 scale of Brief Pain Inventory (BPI) reading should be towards 0. <br/ ><br>;Creatine kinase (CK) testTimepoint: After 10 days- <br/ ><br>less than 320 IU/L for men <br/ ><br>less than 200 IU/L for women than pre intervention study